Chronic Lymphocytic Leukemia International Prognostic INDEX (CLL-IPI) Predicts Prognosis of CLL: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Molica, Stefano
Giannarelli, Diana
Levato, Luciano
Mirabelli, Rosana
Shanafelt, Tait D.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1739
引用
收藏
页数：2
相关论文
共 50 条
  • [21] RETRACTED: Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysis (Retracted Article)
    Molica, Stefano
    Giannarelli, Diana
    [J]. LEUKEMIA, 2021, 35 (02) : 615 - 618
  • [22] Evaluation of the International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) in previously untreated CLL patients receiving chemo-immunotherapy as first-line approach: analysis of 529 cases
    Gentile, Massimo
    Mauro, Francesca Romana
    Reda, Gianluigi
    Rossi, Davide
    Laurenti, Luca
    Del Principe, Maria Ilaria
    Vergata, Tor
    Cutrona, Giovanna
    Angeletti, Ilaria
    Coscia, Marta
    Herishanu, Yair
    Chiarenza, Annalisa
    Molica, Stefano
    Ciolli, Stefania
    Goldschmidt, Neta
    Morabito, Fortunato
    Gaidano, Gianluca
    Polliack, Aaron
    Cortelezzi, Agostino
    Innocenti, Idanna
    Bairey, Osnat
    Shvidel, Lev
    Angrilli, Francesco
    Giordano, Annamaria
    Uccello, Giuseppina
    Petrungaro, Annamaria
    Vigna, Ernesto
    Rago, Angela
    Tripepi, Giovanni
    ZirliK, Katja
    Recchia, Anna Grazia
    Di Raimondo, Francesco
    Del Poeta, Giovanni
    Vergata, Tor
    Ferrarini, Manlio
    Foa, Robin
    Neri, Antonino
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 : 131 - 133
  • [23] CLL-IPI AS A TOOL TO ASSESS OVERALL SURVIVAL OFCLL PATIENTS? A SYSTEMATIC REVIEW AND META-ANALYSIS
    Molica, S.
    Giannarelli, D.
    Mirabelli, R.
    Lentini, M.
    Levato, L.
    Greve, B.
    [J]. HAEMATOLOGICA, 2017, 102 : 120 - 120
  • [24] Prognostic index in chronic lymphocytic leukemia (CLL).
    Garcia-Marco, JA
    Navarro, B
    Bowen, A
    Matutes, E
    Oscier, D
    Catovsky, D
    [J]. BLOOD, 1998, 92 (10) : 515A - 515A
  • [25] Prognostic Impact of the New CLL-IPI Index in a Single Center CLL Spanish Cohort
    Lores, Blanca Ferrer
    Cubells, Blanca Navarro
    Alcala, Alicia Serrano
    Martin, Ivan Castillo
    Casasus, Anabel Teruel
    Martinez, Sandra Ballester
    Martinez, Ariadna Perez
    Campos, Ana Mauricio
    Valero, Inmaculada Castillo
    Gracia, Horacio Cano
    Vercet, Carlos Solano
    Castera, Maria Jose Terol
    [J]. BLOOD, 2016, 128 (22)
  • [26] CHLORAMBUCIL FOR THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) - SYSTEMATIC REVIEW AND META-ANALYSIS
    Vidal, L.
    Gurion, R.
    Gafter-Gvili, A.
    Raanani, P.
    Bairy, O.
    Robak, T.
    Shpilberg, O.
    [J]. HAEMATOLOGICA, 2012, 97 : 57 - 57
  • [27] CHRONIC LYMPHOCYTIC LEUKEMIA: A SIMPLE PROGNOSIS MODEL USING ONLY TWO BIOMARKERS REPRODUCES CLL-IPI RESULTS
    Julio, Delgado
    Michael, Doubek
    Tycho, Baumann
    Jana, Kotaskova
    Pablo, Mozas
    Alfredo, Rivas
    Sarka, Pospisilova
    Emili, Montserrat
    [J]. HAEMATOLOGICA, 2016, 101 : 195 - 196
  • [28] VALIDATION OF THE NEW INTERNATIONAL PROGNOSTIC INDEX FOR CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL-IPI) AND MODIFIED SCORE USED IN THE MD ANDERSON CANCER CENTER (MDACC)
    Isabel, Gonzalez-Gascon y Marin
    Maria, Poza
    Sanchez Maria, Hernandez
    Ana Eugenia, Rodriguez Vicente
    Maria, Infante
    Maria Angeles, Foncillas
    Karen, Marin
    Novas Carolina, Munoz
    Cecilia, Heras
    Jesus Maria, Hernandez Rivas
    Jose Angel, Hernandez
    [J]. HAEMATOLOGICA, 2016, 101 : 338 - 338
  • [29] PROGNOSIS FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    PHILLIPS, E
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 274 - 274
  • [30] Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) - a systematic review and meta-analysis of randomized trials
    Vidal, Liat
    Gurion, Ronit
    Ram, Ron
    Raanani, Pia
    Bairey, Osnat
    Robak, Tadeusz
    Gafter-Gvili, Anat
    Shpilberg, Ofer
    [J]. LEUKEMIA & LYMPHOMA, 2016, 57 (09) : 2047 - 2057
12345